Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Novartis
McKesson
Cantor Fitzgerald
Express Scripts
AstraZeneca
Teva
Daiichi Sankyo
Julphar

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062178

« Back to Dashboard

NDA 062178 describes GRISACTIN ULTRA, which is a drug marketed by Wyeth Ayerst and is included in two NDAs. Additional details are available on the GRISACTIN ULTRA profile page.

The generic ingredient in GRISACTIN ULTRA is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
Summary for 062178
Tradename:GRISACTIN ULTRA
Applicant:Wyeth Ayerst
Ingredient:griseofulvin, ultramicrocrystalline
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength125MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Baxter
QuintilesIMS
Dow
Express Scripts
Farmers Insurance
Colorcon
Cipla
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot